Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1498, 2005-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Appropriate diagnosis appears to improve therapy in CHF
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. :
Access to resources
Recommend
Updated guidelines for diagnosis, treatment of CHF from ESC
Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. :
BNP-guided CHF therapy seems a smart option
Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. :
Tolvaptan: advantages over standard therapy in CHF
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :